Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 15,577 | 0 | 0 | 0 | 0 |
| Cost of Goods | 7,427 | N/A | N/A | N/A | N/A |
| Gross Profit | 8,150 | N/A | N/A | N/A | N/A |
| Operating Expenses | 27,889 | 11,149 | 12,702 | 12,933 | 9,446 |
| Operating Income | -19,312 | -11,149 | -12,702 | -12,933 | -9,446 |
| Interest Expense | 13,845 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 127 | 87 | 8 | 4 |
| Pre-tax Income | -33,157 | -11,022 | -12,615 | -12,924 | -9,442 |
| Income Tax | -646 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -32,511 | -11,022 | -12,615 | -12,924 | -9,442 |
| Net Income | $-32,511 | $-11,022 | $-12,615 | $-12,924 | $-9,442 |
| EPS Basic Total Ops | -3,305.00 | -1,712.50 | -2,050.00 | -7,112.50 | -14,550.00 |
| EPS Basic Continuous Ops | -3,303.99 | -1,711.32 | -2,045.51 | -7,110.59 | -14,130.65 |
| EPS Diluted Total Ops | -3,305.00 | -1,712.50 | -2,050.00 | -7,112.50 | -14,550.00 |
| EPS Diluted Continuous Ops | -3,303.99 | -1,711.32 | -2,045.51 | -7,110.59 | -14,130.65 |
| EPS Diluted Before Non-Recurring Items | -1,450.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,107 | $-11,146 | $-12,698 | $-12,926 | $-9,440 |